← Back to Clinical Trials
Recruiting NCT06526468
Chinese PE Multimodality Imaging Artificial Intelligence Study
Trial Parameters
Condition Pulmonary Embolism
Sponsor China-Japan Friendship Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,500
Sex ALL
Min Age 14 Years
Max Age N/A
Start Date 2010-09-01
Completion 2027-09-01
All Conditions
Interventions
Artificial Intelligence
Brief Summary
The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.
Eligibility Criteria
Inclusion Criteria: * 14 Years and older * Patients suspected of PE Exclusion Criteria: * Pregnant women * Refuse to follow up * Incomplete or discontinued imaging scans * Insufficient quality of image data to allow for analysis